Cresco Labs Inc.
CL
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 697.32M | 715.76M | 726.35M | 734.82M | 747.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 697.32M | 715.76M | 726.35M | 734.82M | 747.27M |
| Cost of Revenue | 354.93M | 359.89M | 360.10M | 370.67M | 392.28M |
| Gross Profit | 342.38M | 355.87M | 366.26M | 364.15M | 354.99M |
| SG&A Expenses | 223.99M | 221.63M | 219.79M | 224.37M | 237.61M |
| Depreciation & Amortization | 21.50M | 21.77M | 26.29M | 26.53M | 25.69M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 600.42M | 603.29M | 606.18M | 621.57M | 655.58M |
| Operating Income | 96.89M | 112.47M | 120.18M | 113.25M | 91.69M |
| Income Before Tax | -27.48M | -10.62M | -853.00K | -131.37M | -119.95M |
| Income Tax Expenses | 46.19M | 49.87M | 55.21M | 30.45M | 34.14M |
| Earnings from Continuing Operations | -73.67 | -60.49 | -56.06 | -161.81 | -154.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.01M | -13.95M | -11.37M | -10.65M | -569.00K |
| Net Income | -83.68M | -74.44M | -67.43M | -172.46M | -154.66M |
| EBIT | 96.89M | 112.47M | 120.18M | 113.25M | 91.69M |
| EBITDA | 153.57M | 171.56M | 185.62M | 179.06M | 156.58M |
| EPS Basic | -0.24 | -0.22 | -0.20 | -0.51 | -0.47 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.03 | -0.04 | 0.05 |
| EPS Diluted | -0.24 | -0.22 | -0.20 | -0.51 | -0.47 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.03 | -0.04 | 0.05 |
| Average Basic Shares Outstanding | 1.39B | 1.38B | 1.37B | 1.36B | 1.33B |
| Average Diluted Shares Outstanding | 1.39B | 1.38B | 1.37B | 1.36B | 1.33B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.24% | -0.27% | -0.30% | -- | -- |